160 results
Page 2 of 8
6-K
EX-99
dojayacu xt45
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-10.1
4odxbpb39bfnm7f4
3 Sep 21
Current report (foreign)
4:30pm
424B5
r1vd2 3sls7umib0
3 Sep 21
Prospectus supplement for primary offering
4:29pm
6-K
EX-99
z4sozfz2x
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
EX-99
2fcrp pvn
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
POS AM
zrpw0
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99
fy5p9bvx1be6v87
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99
hbaag oty15
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
8tjlaa7sj2r3l0o 3w
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
rt92yxq
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
te8nw2jj7ygelqbg
31 Dec 20
Shelf registration (foreign)
4:37pm
6-K
EX-10.1
8xr6h28
25 Sep 20
Current report (foreign)
4:33pm
424B5
pzwpf6178a fshsnp2
25 Sep 20
Prospectus supplement for primary offering
4:30pm
POS AM
3q8jax0 d784xzgin
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
424B3
73doscyhzw81
2 Jul 20
Prospectus supplement
4:28pm
F-1
cfs6 gb91m70g9v
26 Jun 20
Registration statement (foreign)
4:30pm
424B5
ar7 g0asq33argz6
3 Jun 20
Prospectus supplement for primary offering
8:33am
6-K
EX-99
ef226rc6zr 42
3 Jun 20
Current report (foreign)
8:30am